Progression of acromegalic arthropathy despite long-term biochemical control: A prospective, radiological study

European Journal of Endocrinology

Volumn 167, Issue 2, 2012, Pages 235-244

  Claessen, K M J A ^a   Ramautar, S R ^a   Pereira, A M ^a   Smit, J W A ^a   Roelfsema, F ^a   Romijn, J A ^a   Kroon, H M ^a   Kloppenburg, M ^a   Biermasz, N R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RECEPTOR; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALIC ARTHROPATHY; ACROMEGALY; ADULT; AGE; AGED; ARTHROPATHY; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; EXON; FEMALE; FOLLOW UP; GENDER; GENE DELETION; GROWTH HORMONE SECRETING ADENOMA; HAND RADIOGRAPHY; HIP RADIOGRAPHY; HUMAN; JOINT CAVITY; JOINT SPACE NARROWING; KNEE RADIOGRAPHY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OSTEOPHYTE; OSTEOPHYTOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM;

ACROMEGALY; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; JOINT DISEASES; MALE; MIDDLE AGED; OSTEOPHYTE; PROSPECTIVE STUDIES; REMISSION INDUCTION; RISK FACTORS;

EID: 84864351447     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0147     Document Type: Article

References (49)

1. Barkan AL. Acromegalic arthropathy. Pituitary 2001 4 263-264. (doi:10.1023/A:1020754615863)
2. Wassenaar MJE, Biermasz NR, van Duinen N, van der Klaauw AA, Pereira AM, Roelfsema F, Smit JWA, Kroon HM, Kloppenburg M & Romijn JA. High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: a case-control study. European Journal of Endocrinology 2009 160 357-365. (doi:10.1530/EJE- 08-0845)
3. Wassenaar MJ, Biermasz NR, Kloppenburg M, van der Klaauw AA, Tiemensma J, Smit JW, Pereira AM, Roelfsema F, Kroon HM & Romijn JA. Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Hormone & IGF Research 2010 20 226-233. (doi:10.1016/j.ghir.2010.02. 003)
4. Wassenaar MJ, Biermasz NR, Bijsterbosch J, Pereira AM, Meulenbelt I, Smit JW, Roelfsema F, Kroon HM, Romijn JA & Kloppenburg M. Arthropathy in long-term cured acromegaly is characterised by osteophytes without joint space narrowing: a comparison with generalised osteoarthritis. Annals of the Rheumatic Diseases 2011 70 320-325. (doi:10.1136/ard.2010. 131698)
5. Biermasz NR, Wassenaar MJ, van der Klaauw AA, Pereira AM, Smit JW, Roelfsema F, Wolterbeek R, Kroon HM, Kloppenburg M & Romijn JA. Pretreatment insulin-like growth factor-I concentrations predict radiographic osteoarthritis in acromegalic patientswithlongterm cured disease. Journal of Clinical Endocrinology and Metabolism 2009 94 2374-2379. (doi:10.1210/jc.2008-2393)
6. Wassenaar MJ, Biermasz NR, Pereira AM, van der Klaauw AA, Smit JW, Roelfsema F, van der Straaten T, Cazemier M, Hommes DW, Kroon HM, Kloppenburg M, Guchelaar HJ & Romijn JA. The exon-3 deleted growth hormone receptor polymorphism predisposes to long-term complications of acromegaly. Journal of Clinical Endocrinology and Metabolism 2009 94 4671-4678. (doi:10.1210/jc.2009- 1172)
7. Dos SC, Essioux L, Teinturier C, Tauber M, Goffin V & Bougneres P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nature Genetics 2004 36 720-724. (doi:10.1038/ng1379)
8. Biermasz NR, Pereira AM, Smit JW, Romijn JA & Roelfsema F. Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. Journal of Clinical Endocrinology and Metabolism 2005 90 2731-2739. (doi:10.1210/jc.2004-2297)
9. Biermasz NR, van Dulken H & Roelfsema F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. Journal of Clinical Endocrinology and Metabolism 2000 85 4596-4602. (doi:10.1210/jc.85.12.4596)
10. Roelfsema F, van Dulken H & Frolich M. Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clinical Endocrinology 1985 23 555-565. (doi:10. 1111/j.1365-2265.1985.tb01116.x)
11. van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW & Romijn JA. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clinical Endocrinology 2008 69 775-784. (doi:10.1111/j.1365-2265.2008.03288.x)
12. Janssen YJ, Frolich M & Roelfsema F. A low starting dose of genotropin in growth hormone-deficient adults. Journal of Clinical Endocrinology and Metabolism 1997 82 129-135. (doi:10.1210/ jc.82.1.129)
13. Cole TJ. The LMS method for constructing normalized growth standards. European Journal of Clinical Nutrition 1990 44 45-60.
14. Rikken B, van Doorn J, Ringeling A, Van den Brande JL, Massa G & Wit JM. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Hormone Research 1998 50 166-176. (doi:10.1159/000023268)
15. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goossens M & Amselem S. Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. Journal of Biological Chemistry 2000 275 18664-18669. (doi:10.1074/jbc. M001615200)
16. Peterfy C, Li J, Zaim S, Duryea J, Lynch J, Miaux Y, Yu W & Genant HK. Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic jointspace width in the knee: test-retest reproducibility. Skeletal Radiology 2003 32 128-132. (doi:10.1007/s00256-002-0603-z)
17. Altman RD, Hochberg M, Murphy WA Jr, Wolfe F & Lequesne M. Atlas of individual radiographic features in osteoarthritis. Osteoarthritis and Cartilage 1995 3 (Suppl A) 3-70.
18. Botha-Scheepers S, Watt I, Breedveld FC & Kloppenburg M. Reading radiographs in pairs or in chronological order influences radiological progression in osteoarthritis. Rheumatology 2005 44 1452-1455. (doi:10.1093/rheumatology/kei044)
19. Bruynesteyn K, Boers M, Kostense P, van der LS & van der HD. Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change. Annals of the Rheumatic Diseases 2005 64 179-182. (doi:10. 1136/ard.2003.018457)
20. Fortin PR, Stucki G & Katz JN. Measuring relevant change: an emerging challenge in rheumatologic clinical trials. Arthritis and Rheumatism 1995 38 1027-1030. (doi:10.1002/art.1780 380802)
21. Sharma L, Kapoor D & Issa S. Epidemiology of osteoarthritis: an update. Current Opinion in Rheumatology 2006 18 147-156. (doi:10.1097/01.bor. 0000209426.84775.f8)
22. Colao A, Marzullo P, Vallone G, Marinò V, Annecchino M, Ferone D, De Brasi D, Scarpa R, Oriente P & Lombardi G. Reversibility of joint thickening in acromegalic patients: an ultrasonography study. Journal of Clinical Endocrinology and Metabolism 1998 83 2121-2125. (doi:10.1210/jc.83.6. 2121)
23. Colao A, Cannavò S, Marzullo P, Pivonello R, Squadrito S, Vallone G, Almoto B, Bichisao E, Trimarchi F & Lombardi G. Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly. European Journal of Endocrinology 2003 148 31-38. (doi:10.1530/eje.0.1480031)
24. Barkan A. Acromegalic arthropathy and sleep apnea. Journal of Endocrinology 1997 155 (Suppl 1) S41-S44.
25. Neogi T & Zhang Y. Osteoarthritis prevention. Current Opinion in Rheumatology 2011 23 185-191. (doi:10.1097/BOR.0b013e32 834307eb)
26. Nishimura A, Hasegawa M, Kato K, Yamada T, Uchida A & Sudo A. Risk factors for the incidence and progression of radiographic osteoarthritis of the knee among Japanese. International Orthopaedics 2011 35 839-843. (doi:10.1007/s00264- 010-1073-x)
27. Kallman DA, Wigley FM, Scott WW Jr, Hochberg MC & Tobin JD. The longitudinal course of hand osteoarthritis in a male population. Arthritis and Rheumatism 1990 33 1323-1332. (doi:10.1002/art.1780330904)
28. Bijsterbosch J, Watt I, Meulenbelt I, Rosendaal FR, Huizinga TW& Kloppenburg M. Clinical and radiographic disease course of hand osteoarthritis and determinants of outcome after 6 years. Annals of the Rheumatic Diseases 2011 70 68-73. (doi:10.1136/ard.2010. 133017)
29. van Thiel SW, Bax JJ, Biermasz NR, Holman ER, Poldermans D, Roelfsema F, Lamb HJ, van der Wall EE, Smit JW, Romijn JA & Pereira AM. Persistent diastolic dysfunction despite successful long-term octreotide treatment in acromegaly. European Journal of Endocrinology 2005 153 231-238. (doi:10.1530/eje.1.01955)
30. Biermasz NR, Pereira AM, Frolich M, Romijn JA, Veldhuis JD & Roelfsema F. Octreotide represses secretory-burst mass and nonpulsatile secretion but does not restore event frequency or orderly GH secretion in acromegaly. American Journal of Physiology- Endocrinology and Metabolism 2004 286 E25-E30. (doi:10.1152/ ajpendo.00230.2003)
31. Neggers SJ, van Aken MO, de Herder WW, Feelders RA, Janssen JA, Badia X, Webb SM & van der Lely AJ. Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without Pegvisomant. Journal of Clinical Endocrinology and Metabolism 2008 93 3853-3859. (doi:10.1210/jc.2008- 0669)
32. Rubeck KZ, Madsen M, Andreasen CM, Fisker S, Frystyk J & Jorgensen JO. Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery. European Journal of Endocrinology 2010 163 717-726. (doi:10.1530/EJE- 10-0640)
33. Kellgren JH & Lawrence JS. Radiological assessment of osteoarthrosis. Annals of the Rheumatic Diseases 1957 16 494-502. (doi:10.1136/ard.16.4.494)
34. Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA & Roelfsema F. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. Journal of Clinical Endocrinology and Metabolism 2004 89 5369-5376. (doi:10.1210/jc.2004-0669)
35. Neggers SJ, Kopchick JJ, Jorgensen JO & van der Lely AJ. Hypothesis: extra-hepatic acromegaly: a new paradigm? European Journal of Endocrinology 2011 164 11-16. (doi:10.1530/EJE-10-0969)
36. Weiss RE, Reddi AH & Nimni ME. Somatostatin can locally inhibit proliferation and differentiation of cartilage and bone precursor cells. Calcified Tissue International 1981 33 425-430. (doi:10. 1007/BF02409466)
37. Ferrandez MA, Carrascosa A, Audi L & Ballabriga A. Somatostatin effects on cultured human fetal epiphyseal chondrocytes. Pediatric Research 1992 32 571-573. (doi:10.1203/00006450-199211 000-00017)
38. Zapf J, Gosteli-Peter M, Weckbecker G, Hunziker EB & Reinecke M. The somatostatin analog octreotide inhibits GH-stimulated, but not IGF-I-stimulated, bone growth in hypophysectomized rats. Endocrinology 2002 143 2944-2952. (doi:10.1210/en.143.8. 2944)
39. Johansson O & Madsen K. Stimulative effect of somatostatin on cell proliferation in cultured chondrocytes. Medical Biology 1987 65 57-60.
40. Mackie EJ, Trechsel U & Bruns C. Somatostatin receptors are restricted to a subpopulation of osteoblast-like cells during endochondral bone formation. Development 1990 110 1233-1239.
41. Miller A, Doll H, David J & Wass J. Impact of musculoskeletal disease on quality of life in long-standing acromegaly. European Journal of Endocrinology 2008 158 587-593. (doi:10.1530/EJE- 07-0838)
42. Scarpa R, De Brasi D, Pivonello R, Marzullo P, Manguso F, Sodano A, Oriente P, Lombardi G & Colao A. Acromegalic axial arthropathy: a clinical case-control study. Journal of Clinical Endocrinology and Metabolism 2004 89 598-603. (doi:10.1210/ jc.2003-031283)
43. Riyazi N, Meulenbelt I, Kroon HM, Ronday KH, Hellio le Graverand M-P, Rosendaal FR, Breedveld FC, Slagboom PE & Kloppenburg M. Evidence for familial aggregation of hand, hip, and spine but not knee osteoarthritis in siblings with multiple joint involvement: the GARP Study. Annals of the Rheumatic Diseases 2005 64 438-443. (doi:10.1136/ard.2004.024661)
44. Botha-Scheepers S, Riyazi N, Watt I, Rosendaal FR, Slagboom E, Bellamy N, Breedveld FC & Kloppenburg M. Progression of hand osteoarthritis over 2 years: a clinical and radiological follow-up study. Annals of the Rheumatic Diseases 2009 68 1260-1264. (doi:10.1136/ard.2008.087981)
45. Botha-Scheepers SA, Watt I, Slagboom E, Meulenbelt I, Rosendaal FR, Breedveld FC & Kloppenburg M. Influence of familial factors on radiologic disease progression over two years in siblings with osteoarthritis at multiple sites: a prospective longitudinal cohort study. Arthritis and Rheumatism 2007 57 626-632. (doi:10.1002/art.22680)
46. Bagge E, Bjelle A & Svanborg A. Radiographic osteoarthritis in the elderly. A cohort comparison and a longitudinal study of the "70-year old people in Goteborg". Clinical Rheumatology 1992 11 486-491. (doi:10.1007/BF02283103)
47. Busby J, Tobin J, Ettinger W, Roadarmel K & Plato CC. A longitudinal study of osteoarthritis of the hand: the effect of age. Annals of Human Biology 1991 18 417-424. (doi:10.1080/ 03014469100001712)
48. Kalichman L, Kobyliansky E, Seibel MJ & Livshits G. Repeated measurement study of hand osteoarthritis in an apparently healthy Caucasian population. American Journal of Human Biology 2005 17 611-621. (doi:10.1002/ajhb.20417)
49. Reijman M, Pols HA, Bergink AP, Hazes JMW, Belo JN, Lievense AM & Bierma-Zeinstra SMA. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Annals of the Rheumatic Diseases 2007 66 158-162. (doi:10.1136/ard.2006.053538)